Akso Health Group
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +741.3% | +0.0% | +49.9% | +0.0% | +0.9% | +0.0% | +0.0% | -1.4% | -10.6% | +0.0% | +0.0% | |
| – | +741.3% | +0.0% | -29.4% | +0.0% | +95.7% | +0.0% | +0.0% | -90.6% | +930.8% | +0.0% | +0.0% | |
| – | +824.6% | +0.0% | +7.3% | +0.0% | +92.9% | +0.0% | +0.0% | -93.7% | -98.5% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -100.0% | – | +0.0% | +133.7% | +0.0% | +1,251.5% | -75.4% | -59.6% | +0.0% | +0.0% | |
| – | -84.4% | +0.0% | +2.9% | +0.0% | -3.3% | +0.0% | +0.0% | +1.9% | +3.2% | +0.0% | +0.0% | |
| – | – | – | – | +0.0% | -90.4% | +0.0% | +0.0% | +1.9% | +0.0% | -100.0% | – | |
| – | – | – | – | – | – | +0.0% | +0.0% | -13.0% | -99.1% | +0.0% | +0.0% | |
| – | -68.9% | +0.0% | +242.2% | +0.0% | +28.5% | +0.0% | +0.0% | -13.1% | -36.6% | +0.0% | +0.0% | |
| – | -68.9% | +0.0% | +240.4% | +0.0% | +12.9% | +0.0% | +0.0% | -13.0% | -27.5% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +0.0% | +0.0% | – | – | – | – | – | – | |
| – | +2,549.0% | +0.0% | +45.0% | +0.0% | -0.7% | +0.0% | +0.0% | -0.4% | -8.8% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -65.3% | +1,734.8% | -82.2% | +826.6% | -53.2% | +388.6% | -79.5% | +662.2% | -88.9% | +800.4% | -71.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.